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 Periodontal disease: a modifiable 
risk factor for cardiovascular 
disease in ESRD patients? 
 Fran ç ois  Madore 1 
 Accumulating evidence suggests that periodontal disease is associated 
with increased risk of cardiovascular disease (CVD). Several mechanisms 
have been proposed to explain this association. To date, however, a 
causal relation has not been firmly established. In addition, the extent to 
which treatment of periodontal disease might result in lower incidence 
of CVD has not been addressed in any study to date. Further research is 
needed before recommendations are made regarding monitoring and 
therapy of periodontal disease. 
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contribute to systemic inflammation. 
Hence, in view of the proposed role of 
chronic inH ammation in the pathogenesis 
of CVD, a causal relationship between 
periodontal disease and CVD has been 
hypothesized and investigated in recent 
years. 
 In the general population, several epi-
demiological studies have been published 
that evaluated the possible link between 
periodontal disease and incidence of 
CVD. In two recent meta-analyses involv-
ing nearly 150,000 subjects, the incidence 
and prevalence of CVD were found to be 
greater in subjects with evidence of peri-
odontal disease than in those without. 2,3 
On the basis of the latest estimation, evi-
dence of periodontal disease was found 
to be associated with an increased risk of 
CVD of approximately 24 – 35 % . 3 In addi-
tion, almost all of the studies included in 
the most recent meta-analysis provided 
adjustment for major potential confound-
ers such as traditional Framingham risk 
factors, alcohol intake, and socioeco-
nomic status. , us, the results of recent 
systematic reviews and meta-analyses 
suggest that periodontal disease is a sig-
ni% cant risk factor or marker of CVD and 
that this e4 ect is independent of socio-
economic status and traditional risk 
factors for atherosclerosis. 
 Most recent studies focusing on the 
periodontal health of ESRD patients on 
maintenance hemodialysis have reported 
the presence of poor oral hygiene and 
gingival inH ammation. However, conH ict-
ing results have been reported on the 
incidence and severity of periodontal dis-
ease. Whereas some studies reported no 
increase in periodontal disease in ESRD 
patients compared with the general pop-
ulation, other studies have reported 
increased prevalence and severity of 
periodontal disease in ESRD patients. 
Di4 erences in the de% nitions of perio-
dontal disease may have contributed to 
some extent to this discrepancy. Chronic 
renal failure and renal replacement 
therapies also have a number of speci% c 
e4 ects on oral tissues, such as increased 
levels of plaque and calculus, altered 
salivary pH levels, and xerostomia. 4 , e 
reported decrease in utilization of dental-
care services in this population is another 
important effect of renal replacement 
therapy. It is likely that the intense 
demands on personal time that kidney 
disease and dialysis place on these 
patients may decrease the priority of 
seeking oral health care and maintaining 
good oral health. 
 Kshirsagar  et al. 5 (this issue) examined 
the association between CVD mortality 
and periodontal disease in a cohort of 
ESRD patients on chronic hemodialysis. 
Of 168 patients, 68 (40 % ) had moderate /
 severe periodontal disease. Patients 
with moderate / severe disease had a strik-
ingly higher risk of CVD death compared 
with patients with mild or no periodontal 
disease (hazard ratio: 5.3; 95 % con% dence 
interval: 1.5 – 18.9). Adjustment for 
age, sex, dialysis vintage, and some of 
the traditional Framingham risk factors 
(diabetes, hypertension, and smoking 
status) did not diminish the strength of 
the association. Hence, the results of 
Kshirsagar  et al. 5 suggest that part of the 
unexplained CVD burden among ESRD 
patients may be linked to periodontal dis-
ease. In addition, this study raises the 
possibility that eventual treatment of 
periodontal disease may improve CVD 
morbidity and mortality among ESRD 
patients. 
 , e study by Kshirsagar  et al. 5 had a 
number of important limitations. The 
 Cardiovascular disease (CVD) is the most 
important cause of morbidity and mortal-
ity among patients with end-stage renal 
disease (ESRD). In addition to traditional 
risk factors for atherosclerosis, a number 
of nontraditional risk factors have been 
investigated in recent decades. Among 
those, chronic inH ammation has gener-
ated the greatest interest, as several lines 
of evidence have demonstrated the central 
role of chronic inH ammation in the patho-
genesis of atherosclerosis. 
 Periodontal disease is a chronic infec-
tion of the tooth-supporting structures. 1 
It is estimated that about 10 % of the adult 
population and about 30 % of individuals 
over the age of 50 years su4 er from severe 
periodontitis. Common signs of perio-
dontal disease include gum tenderness 
and bleeding, gum recession, alveolar 
bone loss, tooth mobility, and tooth loss. 
Periodontal disease is associated with 
elevations of several markers of chronic 
inflammation. In addition, bacteria 
involved in periodontal disease can 
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study was small and retrospective in 
nature. Complete information was 
missing on a number of important 
confounders. For instance, the authors 
did not have complete information on 
baseline CVD, on nutritional status, on 
medication, and on socioeconomic status. 
Adjustment for any or all of these factors 
could have changed signi% cantly the study 
results and conclusions. In addition, the 
authors could not con% rm the exact cause 
of death of patients. Yet, despite its limita-
tions, this study by Kshirsagar  et al. 5 sug-
gests that periodontal disease may 
represent a modi% able risk factor for CVD 
in ESRD patients. 
 It has been suggested that the associa-
tion between periodontal disease and 
CVD is essentially an artifact owed to 
residual confounding, because of inade-
quate adjustment for socioeconomic 
status, smoking, or other important con-
founders. Although it cannot be ruled out 
that confounding by a factor associated 
with both conditions explains the associa-
tion, several biologically plausible path-
ways have been proposed ( Figure 1 ). First, 
periodontal disease represents a state 
of chronic low-grade infection and, as 
such, may contribute to systemic inH am-
mation. Chronic subgingival infection 
with predominantly Gram-negative 
anaerobic bacteria can stimulate an acute 
phase response and induce an ongoing 
inH ammatory reaction. 6 Consistent with 
this hypothesis, several studies have 
demonstrated that periodontitis patients 
have elevated markers of systemic inH am-
mation, such as C-reactive protein (CRP), 
interleukin-6, haptoglobin, and % brino-
gen. In addition, intervention studies have 
demonstrated a reduction in CRP and 
interleukin-6 levels with periodontal 
therapy. It is of note that in the study by 
Kshirsagar  et al. , 5 CRP levels measured at 
baseline were not found to be higher in 
patients with moderate / severe periodon-
tal disease than in patients with mild or no 
disease. , is % nding is counterintuitive to 
the proposed proinH ammatory hypothe-
sis, but prior studies have also reported a 
lack of association of periodontitis and 
CRP levels in the ESRD population. Per-
haps other mechanisms may be operative 
in ESRD patients. 
 Second, periodontal pathogens are 
capable of entering the systemic circula-
tion and can invade the endothelium of 
major elastic arteries and atheromatous 
plaques. 7 In surgical specimens from 
atherosclerotic plaques, the recovery of 
periodontal pathogens by PCR technique 
has been reported to vary from 14 to 
30 % . A pathogenic role for periodontal 
bacteria in atheroma formation is 
also supported by the ability of bacteria 
such as  Streptococcus sanguis and  Porphy-
romonas gingivalis to induce platelet 
aggregation and to promote monocyte 
and T-cell adhesion. 
 A third biological mechanism by which 
periodontal disease might be associated 
with CVD is related to lipoprotein meta-
bolism. 8 Higher concentrations of total 
and low-density lipoprotein cholesterol 
and triglycerides and lower concentra-
tions of high-density lipoprotein (HDL) 
cholesterol have been observed in 
individuals with periodontal disease. In 
addition, alterations in HDL2 / HDL3 ratio, 
HDL phospholipid content,  and 
sphingomyelin / phosphatidylcholine ratio 
have also been reported in relation to 
periodontal disease. 
 Finally, endothelial-dependent vascular 
dysfunction, an established risk factor for 
CVD, is also associated with periodontal 
disease. 9 Recent studies demonstrated sig-
ni% cantly impaired brachial artery H ow-
mediated dilation in otherwise healthy 
subjects with severe periodontal disease 
compared with control subjects with no 
disease. In addition, several intervention 
trials have demonstrated improved 
H ow-mediated dilation following perio-
dontal therapy. 
 The cumulative evidence presented 
here and in the paper by Kshirsagar  et al. 5 
supports, but does not prove, a causal 
association between periodontal disease 
and CVD. To date, a causal relation has 
not been % rmly established between the 
two disorders. , e existing data, however, 
certainly warrant further studies in this 
% eld. To clarify the link between CVD 
and periodontal disease will require 
a consistent body of evidence from 
epidemiological studies. , ese studies 
should rely on an appropriate and stand-
ardized de% nition of periodontal disease. 
, ey should also take into account socio-
economic status and other important 
confounders, such as nutrition and 
comorbid diseases. Finally, they should 
take into account the speci% c interactions 
between renal failure and periodontal 
disease. 
 To de% nitively establish an etiological 
relation between periodontal disease 
and CVD will require clinical trials 
in which patients are randomized to 
intensive treatment of periodontal disease 
versus usual dental care and followed 














 Figure 1 | Impact of periodontal disease in the pathogenesis of cardiovascular disease. The 
diagram illustrates several mechanisms through which periodontal disease may interact with 
inflammatory pathway components to promote cardiovascular disease.
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date, however, intervention studies on 
the association between periodontal 
disease and CVD have been limited 
to observations on the e4 ects of perio-
dontal therapy on surrogate markers of 
risk for CVD or on pathways related to 
the pathobiology of the disease. The 
extent to which treatment of periodontal 
disease might result in lower incidence 
of CVD has not been addressed in any 
study so far. 
 Taking into account the strength and 
consistency of the association between 
periodontal disease and CVD, the overall 
bene% ts of good oral health, and the negli-
gible risk associated with periodontal ther-
apy, health education to promote better 
oral health should be considered as part of 
current healthy-lifestyle messages designed 
to reduce the burden of CVD in ESRD 
patients. However, further research is 
needed before speci% c recommendations 
are made regarding systematic monitoring 
and therapy of periodontal disease. 
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 Neutrophils in acute kidney injury: 
not neutral any more 
 Subhashini  Bolisetty 1 and  Anupam  Agarwal 1 
 Awad and colleagues elucidate the spatiotemporal profile of neutrophil 
infiltration in the kidney following ischemia – reperfusion injury. Using 
elegant  in vivo labeling techniques, they demonstrate increased 
neutrophil content in the kidney following ischemia – reperfusion, which 
is largely due to transmigration from the circulation into the interstitial 
compartment. The authors also provide mechanistic insights into this 
phenomenon and show that adenosine 2A receptor agonists reduce 
interstitial neutrophil infiltration and improve renal function. 
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neutrophils in the pathogenesis of AKI 
has thus far been controversial. 
 Previous reports demonstrated that 
depletion or inhibition of neutrophil accu-
mulation in the kidney during ischemia –
 reperfusion injury prevented AKI (reviewed 
by Jang and Rabb 5 ). In addition, strategies 
to block neutrophil – endothelial interac-
tions (for example, adhesion molecule anti-
bodies) are protective in animal models of 
AKI. 8 In contrast, others showed no sig-
ni% cant neutrophil accumulation during 
ischemia – reperfusion and neutrophil 
depletion did not protect from AKI. 9,10 Fur-
thermore, nephrologists are oD en consulted 
for AKI in neutropenic patients in bone 
marrow transplant units, adding to the 
controversy about whether neutrophils are 
important in the pathogenesis of AKI. 
 , ese confounding results may be due 
to several reasons. First, the injury model 
used in each of these studies was di4 erent 
and not comparable. Variable times of 
ischemia may have inH uenced the severity 
of injury. Some studies used bilateral 
ischemia or right nephrectomy followed 
by unilateral ischemia. Recent work has 
shown that the systemic response to 
bilateral renal ischemia is greater than that 
to unilateral ischemia. 11 Second, the 
animal species used to study AKI were 
different. Some studies indicate that 
neutrophils accumulate in rodents (mice 
and rats) but not in rabbits following renal 
 Neutrophils, the most abundant leukocyte 
population in circulation, are key e4 ec-
tors of the inH ammatory cascade through 
their functional properties, which that 
include generation of reactive oxygen and 
nitrogen species, chemotaxis, and phago-
cytosis. , e presence of increased neu-
trophils in the kidney has been described 
both in animal models and in biopsies 
from patients with acute kidney injury 
(AKI). 1 Such accumulation occurs par-
ticularly in the peritubular capillary net-
work of the outer medulla as early as 
30  minutes aD er ischemia – reperfusion. 2 
Neutrophils adhere to endothelial cells 
with the help of speci% c adhesion mole-
cules (intercellular adhesion molecule-1 
and P-selectin) and, along with platelets 
and red blood cells, also cause capillary 
plugging, which leads to vascular conges-
tion. 3,4 Degranulation of neutrophils; 
release of proteases, myeloperoxidase, and 
cytokines; and generation of reactive spe-
cies can aggravate injury and damage 
endothelial and epithelial cells in the 
outer medulla. 5 – 7 However, the role of 
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